These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23952987)

  • 1. The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine.
    Rainczuk A; Condina M; Pelzing M; Dolman S; Rao J; Fairweather N; Jobling T; Stephens AN
    J Proteome Res; 2013 Sep; 12(9):4074-88. PubMed ID: 23952987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling.
    Cheng HL; Huang HJ; Ou BY; Chow NH; Chen YW; Tzai TS; Wu CJ; Chen SH
    Proteomics Clin Appl; 2011 Apr; 5(3-4):121-32. PubMed ID: 21322116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
    Moore RG; Brown AK; Miller MC; Skates S; Allard WJ; Verch T; Steinhoff M; Messerlian G; DiSilvestro P; Granai CO; Bast RC
    Gynecol Oncol; 2008 Feb; 108(2):402-8. PubMed ID: 18061248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
    Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
    J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microchip ELISA coupled with cell phone to detect ovarian cancer HE4 biomarker in urine.
    Wang S; Akbas R; Demirci U
    Methods Mol Biol; 2015; 1256():111-21. PubMed ID: 25626535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer biomarkers in urine.
    Chambers AF; Vanderhyden BC
    Clin Cancer Res; 2006 Jan; 12(2):323-7. PubMed ID: 16428467
    [No Abstract]   [Full Text] [Related]  

  • 15. Classifications of ovarian cancer tissues by proteomic patterns.
    Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
    Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
    Zhang Y; Li Y; Qiu F; Qiu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
    Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
    J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteome analysis of cisplatin-induced apoptotic Jurkat T cells by stable isotope labeling with amino acids in cell culture, SDS-PAGE, and LC-MALDI-TOF/TOF MS.
    Schmidt F; Hustoft HK; Strozynski M; Dimmler C; Rudel T; Thiede B
    Electrophoresis; 2007 Dec; 28(23):4359-68. PubMed ID: 17987630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
    Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
    J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.